Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Using Machine Learning to Identify Responders to TACE or HAIC for uHCC
A completed clinical trial evaluated machine learning methods to predict responders to transarterial chemoembolization (TACE) or hepatic art…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT [Phase 2]
A completed Phase 2 trial evaluating hepatic arterial infusion chemotherapy combined with Lenvatinib and PD-1 inhibitors for advanced hepato…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: First in Human Study of SIM0610 in Solid Tumors [Phase 1]
A first-in-human Phase 1 study of SIM0610 in solid tumors is underway, evaluating safety and dosing across multiple indications including No…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating SH006 injection combination therapy in patients with advanced solid tumors, with current focus on liver ca…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma [NA]
A clinical trial update for Yttrium-90 radiation segmentectomy in unresectable hepatocellular carcinoma. The study status is NOT_YET_RECRUIT…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers [Phase 2]
Phase 2 study evaluating the PET imaging agent [18F]FAPI-74 in gastrointestinal cancers has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A phase 1/2 study of TAK-500 with or without pembrolizumab in adults with select locally advanced or metastatic solid tumors; the trial was …
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer [Phase 2]
Phase 2 trial comparing oral cryotherapy with acupressure/acupuncture versus oral cryotherapy alone to prevent oxaliplatin-induced periphera…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study [Phase 2]
Phase 2 RELIEF-NAFLD trial update evaluating lisinopril to prevent progression of non-alcoholic fatty liver disease and nonalcoholic steatoh…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma [Phase 2]
This is a Phase 2 clinical trial update evaluating tislelizumab as consolidation therapy after liver-directed treatment for hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Sintilimab Combined With Stereotactic Body Radiotherapy as Neoadjuvant Therapy for Resectable Hepatocellular [Phase 2]
Phase 2 study evaluating sintilimab in combination with stereotactic body radiotherapy as neoadjuvant therapy for resectable hepatocellular …
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Needle-based Percutaneous Ablation of Liver Tumors. [NA]
A clinical trial evaluating needle-based percutaneous ablation for liver tumors, including hepatocellular carcinoma and metastatic liver can…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev [Phase 3]
A Phase 3 clinical trial evaluating hepatic resection for hepatocellular carcinoma with PVTT, HVTT, or IVCTT after initial atezolizumab/beva…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update examining watch-and-wait versus surgical treatment for hepatocellular carcinoma patients with clinical complet…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: ICIs With and Without MWA in Advanced Hepatocellular Carcinoma
This clinical trial compared immune checkpoint inhibitors with versus without microwave ablation in advanced hepatocellular carcinoma and ha…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/2 study of OC-001 in locally advanced or metastatic cancers has been terminated according to its clinical trials registry listing.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer [Phase 1, Phase 2]
A phase 1/2 study evaluating nivolumab and relatlimab in combination with bevacizumab for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Liver and Biliary Tumor Tissue Registry
Mayo Clinic's Liver and Biliary Tumor Tissue Registry (NCT02917759) has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
This completed clinical trial investigated proteomic biomarkers to predict outcomes after locoregional treatments in hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients
This is a completed clinical trial evaluating whether adding TCC Cocktail to transarterial chemoembolization (TACE) improves survival in unr…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes
This clinical trial update examines the efficacy and outcomes of immune checkpoint inhibitors in patients with hepatocellular carcinoma; the…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma [Phase 4]
Phase 4 real-world trial update evaluating enhanced recovery after surgery–based multimodal preemptive analgesia for perioperative managemen…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study [Phase 2]
A Phase 2 study evaluating Sorafenib in patients with previously treated advanced hepatocellular carcinoma assessed its efficacy and safety …
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer [Phase 2]
Phase 2 clinical trial update evaluating stereotactic body proton radiotherapy for hepatocellular carcinoma; the study has been terminated. …
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC [Phase 2]
Phase 2 trial evaluating HAIC sequential transarterial embolization with lenvatinib and tislelizumab for unresectable hepatocellular carcino…